Last 34 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 35.67 | — | 49.57 | 44.78 | 38.81 | 63.06 | 33.90 | 37.23 | 47.20 | 49.49 | 41.65 | 22.45 | 46.99 | 60.37 | 50.39 | — | 63.24 | 58.24 | 58.33 | 77.79 | 4906.71 |
| — | — | +46.2% | +20.3% | -17.8% | +27.4% | -18.6% | +65.9% | +0.5% | -18.0% | -17.3% | — | -25.7% | +3.7% | -13.6% | — | -98.7% | +2.8% | -43.5% | -10.4% | — | |
| P/S Ratio | 3.31 | 2.90 | 3.48 | 3.57 | 3.53 | 4.23 | 4.78 | 4.22 | 5.07 | 4.43 | 4.21 | 4.10 | 4.11 | 4.20 | 3.72 | 3.88 | 3.36 | 3.90 | 4.48 | 5.01 | 4.73 |
| — | -31.4% | -27.2% | -15.4% | -30.4% | -4.5% | +13.6% | +3.0% | +23.6% | +5.5% | +13.2% | +5.5% | +22.1% | +7.8% | -17.0% | -22.5% | -28.9% | -5.1% | -0.1% | +19.6% | +24.7% | |
| P/B Ratio | 1.59 | 1.52 | 1.66 | 1.76 | 1.67 | 1.99 | 2.15 | 1.96 | 2.33 | 2.11 | 1.99 | 1.87 | 1.90 | 2.04 | 1.76 | 1.71 | 1.46 | 1.77 | 2.01 | 2.24 | 2.08 |
| — | -23.6% | -22.7% | -10.1% | -28.1% | -6.1% | +8.1% | +4.9% | +22.6% | +3.5% | +12.6% | +9.1% | +29.6% | +15.6% | -12.3% | -23.4% | -29.6% | -2.7% | +10.0% | +29.5% | +39.4% | |
| P/FCF | 21.42 | 19.80 | 33.75 | 21.22 | 17.15 | 29.54 | 48.44 | 33.71 | 20.31 | 27.00 | 52.22 | 88.05 | 26.28 | 99.10 | — | 93.65 | 41.83 | 31.52 | — | 256.28 | 46.42 |
| — | -33.0% | -30.3% | -37.0% | -15.6% | +9.4% | -7.3% | -61.7% | -22.7% | -72.8% | — | -6.0% | -37.2% | +214.4% | — | -63.5% | -9.9% | — | — | +527.9% | +32.7% | |
| EV / EBITDA | 14.96 | 33.52 | 14.74 | 18.65 | 15.35 | 19.62 | 16.41 | 16.95 | 21.52 | 19.07 | 17.27 | 19.83 | 18.30 | 19.90 | 17.15 | 27.79 | 17.41 | 18.08 | 20.95 | 25.95 | 24.01 |
| — | +70.8% | -10.2% | +10.0% | -28.7% | +2.9% | -5.0% | -14.5% | +17.6% | -4.2% | +0.7% | -28.7% | +5.1% | +10.1% | -18.2% | +7.1% | -27.5% | -9.8% | -5.7% | +63.5% | -8.7% | |
| EV / EBIT | 28.06 | 1311.99 | 35.48 | 40.26 | 30.45 | 47.80 | 27.57 | 33.89 | 39.12 | 36.36 | 30.75 | 49.51 | 36.09 | 43.24 | 37.27 | 51.36 | 335.78 | 52.72 | 46.56 | 67.28 | 1354.38 |
| — | +2644.9% | +28.7% | +18.8% | -22.2% | +31.5% | -10.4% | -31.5% | +8.4% | -15.9% | -17.5% | -3.6% | -89.3% | -18.0% | -20.0% | -23.7% | -75.2% | +21.5% | -33.1% | +2.6% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.2% | 59.3% | 56.4% | 54.2% | 55.8% | 53.5% | 55.9% | 55.4% | 55.9% | 55.0% | 56.2% | 54.8% | 55.3% | 56.3% | 55.5% | 53.9% | 54.5% | 54.3% | 55.2% | 56.1% | 56.9% |
| — | +11.0% | +0.8% | -2.1% | -0.2% | -2.9% | -0.5% | +0.9% | +0.9% | -2.2% | +1.3% | +1.8% | +1.6% | +3.6% | +0.5% | -4.0% | -4.2% | -6.1% | +3.3% | +24.4% | +23.2% | |
| Operating Margin | 13.1% | 0.4% | 15.5% | 11.5% | 12.7% | 9.5% | 18.9% | 15.8% | 13.5% | 12.7% | 15.0% | 8.8% | 12.6% | 11.1% | 11.4% | 1.0% | 9.6% | 9.0% | 11.2% | 8.5% | 1.0% |
| — | -95.9% | -18.2% | -27.1% | -6.1% | -25.3% | +26.5% | +78.5% | +7.5% | +14.3% | +31.3% | +814.2% | +31.3% | +23.6% | +1.4% | -88.6% | +906.8% | -16.9% | +45.6% | +16.5% | +113.6% | |
| Net Margin | 9.4% | — | 7.0% | 8.0% | 9.1% | 6.8% | 14.2% | 11.4% | 10.7% | 8.9% | 10.1% | 18.2% | 8.8% | 7.0% | 7.4% | -4.5% | 5.4% | 6.7% | 7.7% | 6.5% | 0.1% |
| — | — | -50.6% | -29.7% | -15.4% | -24.1% | +40.3% | -37.5% | +22.4% | +28.0% | +36.3% | +506.3% | +61.6% | +4.5% | -3.6% | -169.1% | +5599.9% | -6.7% | +76.3% | +32.1% | +101.2% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.5% | — | 0.8% | 1.0% | 1.1% | 0.8% | 1.6% | 1.3% | 1.2% | 1.1% | 1.2% | 2.1% | 1.0% | 0.9% | 0.9% | -0.5% | 0.6% | 0.8% | 0.9% | 0.7% | 0.0% |
| — | — | -47.9% | -25.6% | -13.7% | -25.3% | +34.2% | -36.9% | +22.0% | +25.5% | +35.8% | +524.8% | +72.1% | +12.1% | +1.6% | -168.1% | +5538.1% | -4.6% | +94.8% | +43.0% | +101.3% | |
| ROA | 3.2% | — | 0.6% | 0.7% | 0.8% | 0.6% | 1.1% | 0.9% | 0.9% | 0.8% | 0.8% | 1.4% | 0.7% | 0.6% | 0.6% | -0.3% | 0.4% | 0.5% | 0.6% | 0.5% | 0.0% |
| — | — | -48.7% | -26.4% | -13.9% | -25.0% | +36.1% | -35.4% | +25.6% | +30.0% | +40.8% | +525.7% | +66.9% | +8.5% | -1.1% | -168.3% | +5702.8% | -2.7% | +97.1% | +44.2% | +101.3% | |
| ROIC | 4.0% | 0.0% | 1.2% | 0.9% | 1.0% | 0.7% | 1.4% | 1.2% | 1.0% | 1.0% | 1.1% | 0.6% | 0.9% | 0.8% | 0.8% | 0.1% | 0.7% | 0.7% | 0.8% | 0.6% | 0.1% |
| — | -95.5% | -13.7% | -23.2% | -4.2% | -25.8% | +23.7% | +85.7% | +10.9% | +15.3% | +32.8% | +844.7% | +34.5% | +27.9% | +2.8% | -89.1% | +892.6% | -16.1% | +59.6% | +27.0% | +115.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.24 | 0.25 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.25 | 0.25 | 0.26 | 0.26 | 0.26 | 0.22 | 0.22 | 0.23 | 0.23 | 0.24 |
| — | +3.4% | +0.8% | -0.1% | -1.0% | -2.4% | -3.4% | -4.5% | -5.5% | -5.1% | -5.2% | -3.1% | +15.0% | +14.3% | +12.9% | +10.7% | -6.3% | -5.1% | -4.2% | -2.6% | -1.7% | |
| Debt / EBITDA | 2.06 | 19.34 | 7.67 | 9.20 | 7.90 | 8.62 | 6.68 | 7.62 | 8.26 | 8.09 | 7.75 | 9.58 | 8.83 | 9.00 | 8.94 | 14.91 | 9.45 | 8.36 | 8.74 | 10.12 | 10.12 |
| — | +124.3% | +15.0% | +20.8% | -4.4% | +6.6% | -13.9% | -20.5% | -6.4% | -10.1% | -13.3% | -35.7% | -6.5% | +7.7% | +2.4% | +47.3% | -6.6% | -12.6% | -18.1% | +25.6% | -33.4% | |
| Current Ratio | 2.12 | 2.09 | 2.20 | 2.12 | 2.12 | 2.60 | 2.70 | 2.77 | 2.57 | 2.56 | 2.51 | 2.35 | 2.21 | 2.16 | 2.05 | 1.90 | 2.21 | 2.16 | 2.18 | 2.18 | 2.23 |
| — | -19.6% | -18.4% | -23.6% | -17.7% | +1.7% | +7.5% | +17.6% | +16.2% | +18.4% | +22.4% | +24.1% | +0.1% | -0.1% | -5.6% | -13.0% | -0.7% | -5.1% | -13.9% | -1.3% | -2.8% | |
| Quick Ratio | 1.33 | 1.30 | 1.39 | 1.33 | 1.30 | 1.61 | 1.66 | 1.77 | 1.60 | 1.56 | 1.49 | 1.39 | 1.29 | 1.22 | 1.20 | 1.13 | 1.35 | 1.31 | 1.31 | 1.41 | 1.44 |
| — | -19.5% | -16.0% | -25.0% | -18.7% | +3.3% | +11.2% | +28.0% | +24.6% | +28.3% | +24.5% | +23.1% | -4.7% | -6.7% | -8.5% | -20.1% | -6.3% | -10.6% | -21.8% | -4.7% | -3.9% | |
| Interest Coverage | 5.69 | 0.13 | 5.62 | 4.98 | 6.55 | 4.90 | 9.30 | 7.02 | 6.96 | 6.60 | 8.18 | 4.34 | 6.23 | 5.44 | 5.59 | 4.41 | 0.70 | 5.80 | 7.90 | 6.04 | 0.25 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 34 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALC stock.
Alcon Inc.'s current P/E is 35.7x. The average P/E over the last 3 quarters is 44.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Alcon Inc.'s current operating margin is 13.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Alcon Inc.'s business trajectory between earnings reports.